NEXT-GENERATION sequencing use rose in advanced cancer, but access remained uneven across socioeconomic, racial, and ...
"In our study, we showed that fine needle aspiration (FNA) biopsy material can be a good source for next-generation sequencing (NGS) for patients with metastatic prostate cancer. Based on these ...
NGS utilization increased over time but left substantial proportions untested across metastatic breast, prostate, pancreatic, ...
Advances in next-generation sequencing (NGS) and synthetic DNA technologies are reshaping oncology research by enabling earlier cancer detection, more accurate biomarker discovery, and sensitive ...
New data show precision cancer testing still lags for Black, Hispanic, low-income and Medicare/Medicaid patients, delaying ...
Real-World Plasma Thymidine Kinase Activity in High-Risk and Metastatic Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer Treated With Cyclin-Dependent Kinase ...
Machine Learning Model for Predicting Severe Adverse Events in Oncology Patients Using the US Food and Drug Administration Adverse Event Reporting System ClinBioNGS is a modular, fully containerized ...
In this cohort study, most patients with advanced or metastatic cancers did not undergo tumor genomic testing. Low socioeconomic ...
Zacks Investment Research on MSN
PacBio stock up on new FFPE workflow boosting cancer sequencing
PacBio PACB recently announced a new joint workflow with Covaris, a PerkinElmer company and leader in sample preparation ...
In this cohort study, most patients with advanced or metastatic cancers did not undergo tumor genomic testing. Low socioeconomic status, Black race or Hispanic ethnicity, and Medicaid or Medicare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results